Authentic Drug Usage and Tracking with Blockchain Using Mobile Apps
DOI:
https://doi.org/10.3991/ijim.v14i17.16561Keywords:
Blockchain, transactions, decentralized architecture, fake drugs, smart contract, ethereum.Abstract
Tracking drugs became more difficult using the centralized architecture. Decentralized architecture using blockchain technology overcomes the difficulties faced by the centralized network like availability and recovery. Avoiding duplicate or fake drugs created by fake manufacturers is a big challenge in the centralized network. Authentic stock is managed and the supply chain is tracked efficiently using this blockchain technology. This is addressed by using the smart contract which helps to track the movement of drugs from manufacturer to supplier, supplier to the reseller, reseller to pharmacies and finally pharmacies to patient. By default, duplicate drugs or fake drugs are completely avoided by using the blockchain technology. Patients buy drugs without any prescription and it creates a lot of problems in real life. So, Patients cannot buy drugs without authenticated doctor’s prescriptions with the help of a QR Code scanner attached with the prescription which will be implemented using a mobile application and cannot buy excess drugs which might lose someone’s life. With the help of inventory management, the maximum limit of drugs to avoid overdose and pharmacies cannot sell those overdose drugs. Consulting a doctor before buying a drug for even a simple illness is important and it is tracked by using prescriptions provided by authentic doctors. In this project, these challenges are addressed using the smart contract which is written in solidity language and runs on a public ethereum network.
Downloads
Published
How to Cite
Issue
Section
License
The submitting author warrants that the submission is original and that she/he is the author of the submission together with the named co-authors; to the extend the submission incorporates text passages, figures, data or other material from the work of others, the submitting author has obtained any necessary permission.
Articles in this journal are published under the Creative Commons Attribution Licence (CC-BY What does this mean?). This is to get more legal certainty about what readers can do with published articles, and thus a wider dissemination and archiving, which in turn makes publishing with this journal more valuable for you, the authors.
By submitting an article the author grants to this journal the non-exclusive right to publish it. The author retains the copyright and the publishing rights for his article without any restrictions.
This journal has been awarded the SPARC Europe Seal for Open Access Journals (What's this?)